
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Nicardipine Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : NeuroScios | Data Magik | pharm-analyt Labor
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Nicardipine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Subarachnoid Hemorrhage.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 13, 2020
Lead Product(s) : Nicardipine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : NeuroScios | Data Magik | pharm-analyt Labor
Deal Size : Inapplicable
Deal Type : Inapplicable
